Table 3.
Breakdown of Medication Usage by Race
| Type of medication | White patients (n=219) | Black patients (n=178)* | P-value | Total N (%) |
|---|---|---|---|---|
| NSAIDS | 102/219 (46.6%) | 89/177 (50.3%) | .46 | 191/396 (48.2) |
| Acetaminophen | 61/219 (27.9%) | 57/177 (32.2%) | .35 | 118/396 (29.8) |
| Opioids (Total) | 100/219 (45.7%) | 57/177 (32.2%) | .006 | 157/396 (39.6) |
| Weak | 40/159 (25.2%) | 35/155 (22.6%) | .59 | 75/314 (23.9) |
| Strong | 28/147 (19.1%) | 13/133 (9.8%) | .03 | 41/280 (14.6) |
| Long acting | 32/151 (14.6%) | 9/129 (7.0%) | .001 | 41/280 (14.6) |
| Adjuvant | 22/219 (10.1%) | 16/177 (9.0%) | .74 | 38/396 (9.6) |
| Ultram | 18/219 (8.2%) | 9/177 (5.1%) | .22 | 27/396 (6.8) |
| Illicits | 4/219 (1.8%) | 3/177 (1.7%) | .92 | 7/396 (1.8) |
*
One African-American patient did not answer the questions on medication usage
NSAIDS, non-steroidal anti-inflammatories